Coronary collaterals, stenoses, and stents Is a new era of physiologic-guided percutaneous revascularization emerging?* by Samady, Habib et al.
EDITORIAL COMMENT
Coronary Collaterals,
Stenoses, and Stents
Is a New Era of Physiologic-Guided
Percutaneous Revascularization Emerging?*
Habib Samady, MB, CHB, FACC,
Michael Ragosta, MD, FACC,
George A. Beller, MD, MACC
Charlottesville, Virginia
Experimental models of acute myocardial infarction (MI)
have demonstrated that, for a given duration of vessel
occlusion, the amount of collateral circulation together with
the area of myocardium at risk are the two major determi-
nants of final infarct size (1–3). The degree of recruitable
collateral perfusion is highly variable but has been shown to
provide as much as 60% to 80% of normal antegrade
perfusion (4,5), well beyond the 25% required to maintain
myocyte viability and minimize final infarct size (1–3). In
the clinical setting, demonstration of spontaneous angio-
graphic collaterals (6) after MI has been associated with
limited infarct size (7), improved ventricular function (6),
less ventricular aneurysm formation (8), and even improved
survival (9) compared with those without collaterals.
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In 1985, to evaluate the potential collateral reserve of a
myocardial bed, Rentrop et al. (10) described a semiquan-
titative angiographic score of recruitable collaterals, by per-
forming angiography of the contralateral coronary artery
during balloon occlusion of the index lesion. This allowed
evaluation of the potential collateral reserve in a jeopardized
myocardial bed in the event of disease progression leading to
occlusion of the index vessel. While this technique im-
proved our understanding of recruitable collateral circula-
tion in humans, it is semiquantitative and impractical to
apply to widespread patient use (requiring dual arterial
access). Furthermore, the limit of resolution of angiography
is 100 m, and many collaterals are smaller than this.
Therefore, better techniques for practical quantitative as-
sessment of recruitable collaterals were sought.
In the early 1990s, ultra-thin Doppler and pressure
angioplasty guidewires were developed. This led to the
measurement of velocity and pressure in distal vascular beds,
allowing the physiologic assessment of coronary stenoses
and recruitable collateral circulation in humans. On the
premise that blood flow is proportional to velocity when
vessel surface area is constant, in 1991 Ofili et al. (11)
described the Doppler-derived collateral flow index (CFI) as
the ratio of blood velocity in a vessel distal to an occluded
balloon, to blood velocity in the same vessel during patency
(after the reactive hyperemia has subsided) (Fig. 1). Subse-
quently, in 1993 Pijls et al. (12) described the use of
coronary pressure to assess the contribution of antegrade
epicardial and retrograde collateral flow to a given coronary
bed. They defined myocardial fractional flow reserve
(FFRmyo) as the maximal achievable flow in a myocardial
bed in the presence of a stenosis divided by the maximal
flow through the same bed in the theoretic absence of the
stenosis; and fractional collateral flow (FFRcoll) as the
maximum fraction of total myocardial blood flow contrib-
uted to a bed by the collateral circulation. They demon-
strated that, by simultaneously measuring mean aortic
pressure (Pa), mean coronary pressure distal to a stenosis
(Pd), coronary wedge pressure (Pw), and central venous
pressure (Pv) during maximal hyperemia (when resistance is
minimal and constant), the following equations represent
FFRmyo and FFRcoll:
FFRmyo  (Pd  Pv)/(Pa  Pv)
FFRcoll  (Pw  Pv)/(Pa  Pv)
Fractional collateral flow has also been termed pressure-
derived CFI (Fig. 1).
Both pressure-derived and Doppler-derived CFIs have
been clinically validated. Pressure-derived CFI (FFRcoll)
was shown to have an excellent correlation with extent and
severity of 99mTc-sestamibi defect in the territory of an
occluded artery during balloon angioplasty in the catheter-
ization laboratory (13). Doppler-derived CFI has been
shown to have an excellent correlation with pressure-derived
CFI, and low values for both indexes were found to be
highly predictive of ischemic ST-segment changes on elec-
trocardiography during balloon occlusion (14).
These simple quantitative physiologic indexes of re-
cruitable collateral flow in humans have heralded the inves-
tigation of the protective value of recruitable collaterals in
nonocclusive stenotic vessels undergoing percutaneous cor-
onary intervention (PCI). To assess the clinical utility of
recruitable collaterals during PCI, Pijls et al. (15) compared
FFRcoll in 120 patients with single-vessel disease undergo-
ing PCI to ischemic ST-segment changes on electrocardi-
ography during balloon occlusion, and evaluated the predic-
tive value of FFRcoll on cardiac outcomes. They found that
when the FFRcoll was high (24%), patients were very
unlikely to develop electrocardiographic evidence of isch-
emia during balloon inflation, and had an almost eightfold
lower risk of developing a subsequent acute cardiac event
(unstable angina or MI), compared with patients with low
(24%) FFRcoll. In contrast, Wahl et al. (16) found that
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patients undergoing PCI of lesions with high recruitable
collateral flow had higher restenosis rates than those with
low recruitable collateral flow.
Given these apparently conflicting studies regarding the
association of recruitable collaterals during PCI and recur-
rent cardiac events, the study by Billinger et al. (17)
published in this issue of the Journal is timely and sheds
important light on the matter. They report on the long-term
ischemic cardiac event rate of a large series of patients with
stable angina who underwent quantitative assessment of
recruitable CFI at the time of PCI, measured either by the
Doppler-derived or pressure-derived CFI. Among 403 pa-
tients studied, 134 (33%) had high CFI (25%) and 269
(67%) had low CFI (25%). There were no significant
differences in cardiac risk factors, medications, or left
ventricular ejection fraction between the two groups. Pa-
tients with high CFI were found to have higher grade
stenoses, greater extent of coronary disease, and less angina
and ST-segment changes during balloon inflation. The
incidence of all subsequent cardiac events (death, MI,
unstable angina, and stable angina) was similar in the two
groups at a mean of two year follow-up (23% in high
collateral group vs. 20% in low collateral group, p  NS).
Consistent with the Pijls et al. study (15), the authors
observed significantly fewer unstable cardiac events (death,
MI, or unstable angina) in patients with high compared
with low CFI (2.2% vs. 9%, respectively; p  0.01).
However, they observed a higher incidence of stable angina in
patients with high CFI compared with the low collateral
group (21% vs. 12%; p  0.01). Interestingly, angiographi-
cally assessed collaterals had no prognostic value in predict-
ing either stable or unstable ischemic cardiac events in this
patient population.
At first glance, the association of higher recruitable
collateral flow during PCI with lower subsequent incidence
of unstable cardiac events, yet higher stable angina, may
appear somewhat discordant. Indeed, it is difficult to have a
definitive explanation for these findings without angio-
graphic follow-up to help determine which cardiac events
were related to restenosis of the index PCI lesions versus
new lesions in other areas within the coronary vasculature.
Nevertheless, it is clear that patients who are capable of
recruiting brisk collaterals in the event of progression of
coronary obstruction are protected from acute ischemic
events. The higher incidence of stable angina in the patients
with high CFI may be related to a greater extent of coronary
artery disease (CAD) observed in these patients compared
with those with low CFI (2.0  0.8 vessel CAD vs. 1.8 
0.7 vessel CAD, respectively, p  0.05). This is consistent
with our previous observation of a greater prevalence and
extent of exercise-induced ischemia on 201Tl scintigraphy in
patients with angiographically visible collaterals versus those
Figure 1. Schematic diagram of measurement of Doppler-derived collateral flow index (Doppler-CFI) and pressure-derived collateral flow index
(Pressure-CFI), also known as FFRcoll, during balloon inflation of the index lesion during percutaneous revascularization. Pa  mean aortic pressure; Pv 
central venous pressure; Pw  coronary wedge pressure; Voccl  blood velocity distal to balloon occlusion; Vpatent  blood velocity in patent vessel after
reactive coronary hyperemia has subsided. See text for details. Reprinted with permission from the American College of Cardiology Foundation Journal of
the American College of Cardiology, 1998;32:1272–9.
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without visible collaterals (18). An alternative explanation
for the higher incidence of stable angina in patients with
high recruitable collaterals is that such patients may develop
restenosis more commonly, as previously reported by Wahl
et al. (16), albeit with a more gradual clinical presentation.
The mechanism by which recruitable collateral distal to an
angioplastied lesion might influence restenosis is not known
and difficult to explain. One potential pathophysiologic
explanation might be that, as the restenotic process begins
limiting antegrade blood flow, abundant collateral flow is
recruited and competes with antegrade flow, somehow
accelerating the process of restenosis. While these collaterals
would provide enough myocardial blood flow to avoid an
unstable coronary syndrome, they may not provide adequate
flow during exercise, resulting in a stable anginal pattern.
There are a several limitations to the Billinger et al. study
(17) that deserve mention. First, for accurate assessment of
pressure-derived CFI, Pv should be measured and not
estimated as done in this study. Second, Pw should be
measured during maximal hyperemia induced by intrave-
nous vasodilators (12). Although balloon occlusion itself is a
vasodilatory stimulus, it is possible that some of patients
who did not achieve a high pressure-derived CFI would
have done so if hyperemia were induced with a vasodilator.
Third, given the fact that the results of this study critically
depend on the distinction between stable and unstable
coronary syndromes, the exact definition of these syndromes
is not made clear enough in the Billinger et al. study (17).
Finally, almost 10% of the initial study population were lost
to follow-up, and, in 19% of patients, follow-up information
was obtained from the patients’ physicians who may not
have had sufficiently detailed information on the patients’
status to distinguish stable from unstable angina.
Despite these limitations the study by Billinger et al. (17)
is an important, large clinical study providing evidence for
the association between physiologically assessed robust re-
cruitable collaterals in patients with CAD undergoing PCI
and a low rate of subsequent unstable ischemic cardiac
events.
While the value of spontaneous coronary collateral flow
after MI has been established, the present study by Billinger
et al. (17) provides evidence of the protective value of
recruitable collaterals at the time of PCI on subsequent acute
cardiac events. Furthermore, it highlights the practical
utility of physiologic assessment, as an adjunct to angiogra-
phy, in the catheterization laboratory. With up to 60% of
patients arriving to the catheterization laboratory without
prior noninvasive evaluation (19), physiologic assessment of
coronary lesions can provide valuable complementary infor-
mation to angiography for directing revascularization. In-
deed, several recent studies have examined the outcomes of
patients undergoing physiologic-guided revascularization. A
study by Bech et al. (20) suggests favorable outcomes in
deferring PCI compared with performing PCI in patients
with angiographically intermediate single-vessel disease
who have physiologically nonsignificant flow limitation
(FFR  0.75). Likewise, in patients with multivessel CAD
referred for coronary artery bypass surgery, those undergo-
ing fractional flow reserve-guided percutaneous revascular-
ization instead of coronary artery bypass surgery appear to
have comparable two-year outcomes to patients undergoing
coronary artery bypass surgery (21). Even in the difficult
setting of intermediate left main stenosis, preliminary data
suggest that physiologic assessment with fractional flow
reserve can be used to safely defer coronary artery bypass
surgery (22).
This study also contributes to the growing body of
evidence regarding the prognostic value of physiologic
assessment in the catheterization laboratory. For instance,
while fractional flow reserve assessment had previously been
shown to correlate well with intravascular ultrasound for
evaluation of optimal stent deployment (23), only recently
has its prognostic value been demonstrated in this setting
(24). Indeed, a large multicenter registry of patients under-
going fractional flow reserve assessment after coronary
stenting demonstrated post-stent fractional flow reserve to
be the most powerful predictor of future major adverse
cardiac events compared with other clinical, angiographic,
and hemodynamic variables assessed (24). Patients with a
post-stent fractional flow reserve of 0.90 had an eight
times lower risk of subsequent major adverse cardiac event
(death, MI, or revascularization) in the first year after PCI.
Collateral flow index was not measured in that study, so the
comparative prognostic value of CFI and post-stent frac-
tional flow reserve is not known. Also, it is currently not
known whether the prognostic value of these physiologic
tools relates to predicting restenosis, progression of athero-
sclerosis, or the occurrence of de novo lesions. Only large-
scale outcome studies of patients undergoing physiologic-
guided PCI, with angiographic follow-up, can answer these
important questions.
These powerful physiologic predictors of major adverse
cardiac events after PCI, measured during the index inter-
vention in the catheterization laboratory, are likely to
remain valuable tools even in the era of drug-eluting stents.
The estimated incremental cost of unrestricted use of
drug-eluting stents may be prohibitive. Therefore,
physiologic-based selection of patients in whom PCI with
conventional “bare” stents may result in excellent long-term
outcomes may avert the need for ubiquitous use of drug-
eluting stents. Clearly, prospective randomized trials of
physiologic- versus angiographic-guided percutaneous re-
vascularization are warranted to contain the cost and improve
long-term outcomes. Perhaps a new era of physiologic-guided
percutaneous revascularization is emerging!
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